Free Trial

Mangoceuticals (MGRX) Institutional Ownership

Mangoceuticals logo
$0.41 +0.07 (+21.73%)
As of 03:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Mangoceuticals (NASDAQ:MGRX)

Current
Institutional Ownership
Percentage
56.72%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$1.34M
Number of
Institutional Sellers
(last 12 months)
0
Get MGRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mangoceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MGRX Institutional Buying and Selling by Quarter

Mangoceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2026Virtu Financial LLC33,462$25K0.0%N/A0.205%
2/18/2026Ikarian Capital LLC138,146$102K0.0%N/A0.848%
2/18/2026Boothbay Fund Management LLC38,441$28K0.0%N/A0.236%
2/18/2026Armistice Capital LLC1,536,000$1.14M0.0%N/A9.429%
2/12/2026Jane Street Group LLC47,503$35K0.0%N/A0.292%
8/8/2025Geode Capital Management LLC26,498$40K0.0%+35.4%0.513%
2/12/2025Geode Capital Management LLC12,003$29K0.0%-90.9%0.482%
2/4/2025Ackerman Capital Advisors LLC34,500$83K0.0%-96.0%1.386%
10/24/2024Ackerman Capital Advisors LLC873,356$206K0.1%N/A3.519%
8/8/2023Colonial River Wealth Management LLC36,100$66K0.0%N/A0.216%
7/28/2023Independent Advisor Alliance26,000$48K0.0%N/A0.162%


MGRX Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Mangoceuticals shares: Armistice Capital LLC ($1.14M), Ikarian Capital LLC ($102K), Ackerman Capital Advisors LLC ($83K), Geode Capital Management LLC ($40K), Jane Street Group LLC ($35K), and Boothbay Fund Management LLC ($28K), and Virtu Financial LLC ($25K).Learn more on Mangoceuticals' institutional investors.

56.72% of Mangoceuticals' stock is owned by institutional investors. Learn more on MGRX's institutional investor holdings.

The following institutional investors have purchased Mangoceuticals' stock in the last 24 months: Armistice Capital LLC ($1.54M), Ackerman Capital Advisors LLC ($873.36K), Ikarian Capital LLC ($138.15K), Jane Street Group LLC ($47.50K), Boothbay Fund Management LLC ($38.44K), Virtu Financial LLC ($33.46K), and Geode Capital Management LLC ($6.93K).

Institutional investors have bought a total of 1,800,480 shares in the last 24 months. This purchase volume represents approximately $1.34M in transactions.



This page (NASDAQ:MGRX) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners